24 results
Running out of Analgesia and Sedation Medications due to #COVID19?  Anand Swaminathan, MD has put
and Analgesia Alternative ... #management #covid19 ... treatment #sarscov2 #criticalcare ... sedative #analgesia #pharmacology ... #alternatives #
Alternatives to opioids for pain management in the emergency department decreases opioid usage and maintains patient
Alternatives to ... opioids for pain management ... #Pharmacology # ... NonOpioid #Alternatives ... PainSyndromes #Indications
Massive Hemoptysis - Differential Diagnosis Framework and Management
Definition: 150-600 mL over 24 hours
Differential Diagnosis:
 • Tracheobronchial:
Massive Hemoptysis - Differential ... over 24 hours Differential ... : 1) Indications ... Massive #Hemoptysis #Differential ... #pulmonary #criticalcare
Triptan Selection - Migraine Management
Choosing triptans:
 • Reponse to given triptan do not predict to others
Selection - Migraine Management ... month to avoid medication-overuse ... higher dose • Alternative ... triptan • Alternative ... treatment #neurology #pharmacology
Shock - Differential Diagnosis Framework
 - MAP <65. SBP <90, drop in SBP > 40
 -
Shock - Differential ... Failure, Toxins/Medications ... Sophia_Hayes_MD #Shock #Differential ... #Diagnosis #criticalcare ... algorithm #treatment #management
High yield pharmacology notes
#pharmacology #cardiology #management #medications #criticalcare #treatment
High yield pharmacology ... notes #pharmacology ... #cardiology #management ... #medications #criticalcare
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
Infection General Management ... malabsorption Alternative ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Neutropenia 2-7% Alternative ... Siltuximab #COVID19 #Pharmacology ... #Management #Medications
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
daily (AI), or Alternative ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
diarrhea as an alternative ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology